Close Menu

NEW YORK – Molecular diagnostic reagent developer BioGX and Bosch Healthcare Solutions, a subsidiary of the Bosch Group, announced Wednesday a partnership to develop point-of-care infectious disease tests for Bosch's Vivalytic platform.

Birmingham, Alabama-based BioGX will develop, manufacture, and supply reagents for the Vivalytic cartridges, along with providing custom reagent manufacturing services for Vivalytic open system users. The companies said they will work together to seek regulatory approvals in different countries for in vitro diagnostic use.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.